Simplex Trading
BCDA icon

Simplex Trading’s BioCardia BCDA Stock Holding History

Simplex Trading’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,240
Closed -$12K – 8834
2023
Q4 		$12K Sell
1,240
-40
-3% -$325 ﹤0.01% 7281
2023
Q3 		$8K Buy
1,280
+647
+102% +$10.9K ﹤0.01% 7304
2023
Q2 		$25K Sell
633
-1,720
-73% -$53K ﹤0.01% 6529
2023
Q1 		$68K Sell
2,353
-1,127
-32% -$37.4K ﹤0.01% 5574
2022
Q4 		$109K Sell
3,480
-647
-16% -$18.4K ﹤0.01% 4957
2022
Q3 		$120K Buy
4,127
+4,060
+6,060% +$105K ﹤0.01% 5261
2022
Q2 		$1K Sell
67
-66
-50% -$1.58K ﹤0.01% 9517
2022
Q1 		$4K Buy
+133
New +$3.95K ﹤0.01% 9515
2021
Q4 		– Sell
-573
Closed -$33K – 10466
2021
Q3 		$33K Hold
573
– – ﹤0.01% 7988
2021
Q2 		$34K Buy
+573
New +$34.8K ﹤0.01% 8106

Other funds holding BCDA

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's BCDA Position: Q2 2024 in Review

Simplex Trading sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 480 shares — an estimated $2K sold.

Simplex Trading first reported a position in BCDA in Q1 2021 and held it in 10 quarters. The position peaked at $100K in Q1 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

  • Simplex Trading reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 480 BioCardia shares in Q2 2024, an estimated $2K.
  • Simplex Trading first reported a position in BioCardia in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's BioCardia position peaked at $100K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.